ClinicalTrials.Veeva

Menu

Digital Home Ovulation Test One Cycle at Home Study

Swiss Precision Diagnostics (SPD) logo

Swiss Precision Diagnostics (SPD)

Status

Completed

Conditions

Fertility
Pregnancy

Treatments

Device: Home Ovulation Test

Study type

Observational

Funder types

Industry

Identifiers

NCT04667845
PROTOCOL-1200

Details and patient eligibility

About

This study will assess the usability of a Digital Home Ovulation Test when used at home by lay-users seeking to conceive.

Full description

This study will assess the ease of use of a Digital Home Ovulation Test when used by lay-users for one cycle in their home environment. The home ovulation test to be used in the study is a digital home ovulation test used to detect luteinising hormone (LH) and Estrone-3-Glucuronide (E3G) in urine to identify when ovulation is imminent.

A sample size of 120 volunteers (minimum) will provide adequate information for assessing the usability of the home ovulation test. Usability of the test will be assessed through a questionnaire completed at the end of the study.

This observational study will be conducted remotely and volunteers representative of the intended user (lay-users) will be recruited.

Enrollment

125 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female
  • Aged 18 to 45 years
  • Seeking to conceive
  • Willing to give informed consent and comply with the investigational procedures

Exclusion criteria

  • Taking medication, or has known condition which means they should not get pregnant.

  • Currently pregnant or breastfeeding

  • Used the digital ovulation test within the last six months

  • Currently or previously employed by Swiss Precision Diagnostics (SPD), Abbott, Alere, Unipath, P&G or affiliates

  • Has an immediate* relative currently or previously (within past 5 years) employed by SPD, Abbott, Alere, Unipath or P&G, or affiliates

    *Immediate relatives are defined as parents, children, siblings or partner/spouse

  • Is a qualified or trainee healthcare professional (HCP)

  • Has professional experience of using dipstick type tests or lateral flow devices

  • Using any treatment which may affect the menstrual cycle (e.g. contraceptive pill)

  • Using infertility medications or hormone replacement medications containing Luteinising Hormone (LH) or Human Chorionic Gonadotrophin (hCG) (e.g. Pregnyl®)

  • Using or undergoing any other medical treatment for fertility such as ovulation drugs, artificial insemination and assisted fertility such as In vitro fertilization (IVF) or Intracytoplasmic sperm injection (ICSI)

  • Peri-or post-menopausal, e.g. experiencing symptoms: irregular menstrual periods, hot flushes, night sweats, sleep disturbances and/or moods swings

  • Has been diagnosed with polycystic ovarian syndrome (PCOS)

  • Has PCOS symptoms e.g. very irregular cycles, hirsutism

  • Has abnormal liver or kidney function

  • Is taking antibiotics containing tetracycline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems